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Abstract 
The identification of antenatal depression is critical but poorly conducted. The aim of this 
study was to construct a simplified depression survey scale and to verify its efficacy as a 
pre-screening for antenatal depression. A total of 494 pregnant women in the third trimester 
of gestation who had received antenatal care at Seoul St. Mary’s Hospital from July 2009 to 
June 2010 were included. The Edinburgh Postnatal Depression Scale (EPDS) questionnaire 
was completed by them. The subjects were randomly divided into two groups: 250 of training 
set and 244 of validation set. We designed a simplified questionnaire comprising two items of 
EPDS using the training set. We then validated its efficacy with the training set and reaffirmed 
the results with the validation set. The sum of item 5 (scare or panic) and item 8 (sadness or 
misery) explained 75.5% of the total score of the EPDS (AUC = 0.947). Using a score of 3 as 
a cut-off value of the simplified scale, sensitivity was 92.4% and specificity was 86.3%. The 
positive and negative predictive values were 56.2% and 98.4%, retrospectively. This study 
suggests that the simplified EPDS can be an efficient instrument to rule out depression during 
pregnancy. 
Key  words:  Antenatal  depression,  Edinburgh  Postnatal  Depression  Scale,  Screening,  Perinatal 
mental health, Depression. 
Introduction 
Many women experience physiological and so-
cial changes related to pregnancy and want to adapt 
to these changes. However, changing circumstances 
without preparation can cause mental and emotional 
problems, and the influence of hormones associated 
with pregnancy can aggravate the occurrence of these 
problems. For these reasons, women of childbearing 
age can be at high risk for depressive disorder (1). 
Perinatal  mental  disorder  is  characterized  by 
depression, anxiety, or somatic symptoms that occur 
during the antenatal and postnatal periods. However, 
postpartum  depression  is  the  only  perinatal  mental 
disorder that has been the focus of extensive studies 
(2, 3). It has only been during the last decade that a 
shift from the narrow concept of postpartum depres-
sion to a consideration of the spectrum of depressive 
symptoms arising throughout the perinatal period has 
been observed (4).  
Antenatal depression is a nonpsychotic depres-
sive  episode  that  begins  during  pregnancy.  It  is  as 
common  as  postpartum  depression,  but  less  docu-
mented  (5).  Some  studies  have  found  that  the  inci-
dence  of  depression  is  similar  during  the  antenatal 
and  postnatal  periods  (6,  7).  Other  studies  suggest 
that antenatal depression may be more prevalent than 
postpartum depression and that the incidence of an-
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tenatal depression is as high as 20%, twice as frequent 
as the reported rate of 11% for postpartum depression 
(8-10). 
Antenatal  depression  had  been  identified  as  a 
risk factor for postpartum depression and for adverse 
obstetric  and  neonatal  outcomes  (11-13).  Neonatal 
adverse outcomes include preterm labour, low birth 
weight,  and  neonatal  complications  associated  with 
increased  morbidity  and  mortality  in  the  infant 
(14-17). Untreated antenatal depression has also been 
associated  with  smaller  head  circumference,  lower 
Apgar scores, higher cortisol levels at birth, alteration 
in heart rate variability, and increased admissions to 
neonatal  care  units  (18-20).  Moreover,  adverse 
long-term effects on early child development may be 
associated  with  depressive  symptoms  during  preg-
nancy (21). 
Only  a  minority  of  pregnant  women  suffering 
from depression are identified by health care provid-
ers  despite  its  importance  (22-24).  A  major  impedi-
ment to depression detection is the difficulty in the 
administration of depression screening tests in busy 
clinical  settings  (25).  The  instruments  for  screening 
depression  can  be  used  during  pregnancy  and  the 
postpartum period, but they generally require at least 
5 minutes to complete and even longer to interpret. 
If there were simplified screening instruments, 
obstetrical  health  care  providers  would  be  able  to 
identify the women who have depressive symptoms 
easier. Therefore, the purposes of our study are: (1) to 
design  a  simplified  depression  scale  that  is  easy  to 
administer in the clinic and (2) to assess the validity of 
the newly developed instrument as a pre-screen for 
antenatal depression.  
Methods 
Study population 
All  pregnant  women  in  the  third  trimester  of 
gestation who had received antenatal care at Seoul St. 
Mary’s  Hospital  from  July  2009  to  June  2010  were 
asked  to  participate  in  this  prospective  study.  The 
aims and procedures of the study were explained to 
the women when they visited the hospital for ante-
natal care. A total of 494 pregnant women who pro-
vided consent were included in the study, and written 
consent  was  obtained.  Women  who  did  not  speak 
Korean  or  had  missing  depression  screening  data 
were excluded. The Korean version of the Edinburgh 
Postnatal  Depression  Scale  (EPDS)  was  completed 
while  the  women  were  waiting  for  their  prenatal 
medical appointment, and all were scored by one re-
searcher. Participants also completed a questionnaire 
that  recorded  their  socio-demographic  factors  and 
obstetrical characteristics. The socio-demographic and 
obstetrical  risk  factors  questionnaire  included  ques-
tions on age, pregestational body mass index (BMI), 
parity,  gestational  age,  highest  level  of  education 
completed, occupation, alcohol and smoking habits, 
past and/or current health problems, and past history 
of adverse obstetrical outcomes such as abortion or 
preterm  delivery.  The  study  was  approved  by  the 
Ethics  Committees  at  the  Clinical  Research  Coordi-
nating  Center  of  the  Catholic  Medical  Center 
(KC09OIS01368). 
Measures of depressive symptoms 
Depressive symptoms were measured using the 
EPDS, a 10-item self-report scale. This instrument was 
designed by Cox et al. to screen for postpartum de-
pression  (26).  It  is  the  most  widely  used  screening 
questionnaire for postpartum depression (27), and has 
been widely validated for not only this condition but 
also antenatal depression (28, 29). In addition, it is the 
only  rating  scale  for  depression  that  has  been  vali-
dated  as  applicable  to  the  antenatal  period(30).  For 
each item, women are asked to select one of four re-
sponses that most closely describe how they have felt 
over the past 7 days. Each response has a value be-
tween 0 and 3; scores for the 10 items are summed to 
give a total score between 0 and 30. We chose to re-
gard  an  EPDS  score  ≥12  as  indicating  depression. 
Although a number of cut-off points have been used, 
sensitivity for the identification of major depression in 
pregnancy has been found to be >95% with a specific-
ity of >95% at this cut-off point (31). Cronbach’s alpha 
coefficient of the EPDS in this study was 0.82. 
Statistical analysis 
The  subjects  were  randomly  divided  into  two 
groups: 250 of training set and 244 of validation set. 
We analyzed the relationships between each item or 
subset  of  items  and  the  total  EPDS  score  for  the 
training data set. Within the two groups, the number 
of women found to be depressive by the EPDS was 
approximately equal; that is, 38 in the training set and 
41 in the validation set. To determine the items and 
groups  of  items  that  best  predicted  the  total  EPDS 
score, Pearson correlation analysis and multiple linear 
regression  with  best  subset  selection  options  were 
performed, and the coefficients of determination were 
used for selecting the reduced set of items. 
We  chose  the  cut-off  point  and  evaluated  the 
screening performance of the simplified EPDS by re-
ceiver-operating characteristic (ROC) curve analysis. 
We present here the resulting sensitivity, specificity, 
positive  predictive  value, negative  predictive  value, 
and the area under the curve (AUC) and correspond-Int. J. Med. Sci. 2012, 9 
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ing 95% confidence intervals (CIs) for the determined 
cut-off value. 
To confirm the validity of results obtained from 
the training data set, we applied the same procedures 
to the validation data set and total data set. Statistical 
analysis of the socio-demographic and obstetrical data 
was  carried  out  using  Student’s  t-test  and  Fisher’s 
exact  test.  SAS  version  9.1  software  (SAS  Institute, 
Cary, NC, USA) was used for all statistical analyses. 
All  tests  were  two-tailed,  and  a  P value  <0.05  was 
regarded as statistically significant. 
Results 
Characteristics of study population 
A total of 494 pregnant women joined the study 
and completed the questionnaire. Table 1 presents the 
socio-demographic characteristics of the participants. 
Overall, the participants comprised primarily highly 
educated  women  with  demographic  characteristics 
consistent  with  that  background.  More  than  half  of 
the participants were between the ages of 30 and 35. 
The proportion of primipara and multipara was sim-
ilar. The scores of 79 of 494 women were ≥12 points, 
which is the cut-off value to define depressive symp-
toms by EPDS. The distribution of demographic var-
iables  did  not  vary  significantly  between  the  two 
groups, ‘depressed’ and ‘not depressed’. Only occu-
pational  status  was  significantly  associated  with  a 
positive EPDS screen (P = 0.038).  
The total EPDS score averages were 7.38 ± 4.27 in 
the  whole  study  population,  14.7  ±  2.75  in  the  de-
pressed group, and 5.98 ± 2.84 in the not depressed 
group (P < 0.0001). The scores of all items showed a 
significant  difference  between  the  two  groups  (P  < 
0.0001).  Items  that  obtained  high  scores  in  both 
groups  were  item  3  (self-blame),  item  4  (anxiety  or 
worry), and item 5 (scare or panic). Item 8 (sadness or 
misery) was scored high in the depressed group (Ta-
ble 2). 
Table 1. Demographic characteristics of study population. 
  Depressed (n = 79)  Not depressed (n = 415)  P value* 
Age (yr)  32.6 ± 4.08  32.3 ± 3.60  0.460 
Pregestational BMI (kg/m2)  21.1 ± 2.95  20.7 ± 2.69  0.189 
Parity      0.386 
Primipara  42 (53.2)  248 (59.9)   
Multipara  37 (46.8)  167 (40.2)   
Gestational age (wk)  33.7 ± 3.35  33.8 ± 3.57  0.940 
Education      0.271 
Less than high school  0 (0.0)  1 (0.2)   
High school graduate  11 (14.1)  35 (8.5)   
College graduate  67 (85.9)  377 (91.3)   
Occupation      0.038 
Not employed  14 (17.7)  74 (17.9)   
Quit after pregnancy  31 (39.2)  106 (25.6)   
Employed  34 (43.0)  234 (56.5)   
Alcohol      0.095 
Yes  2 (2.6)  2 (0.4)   
Quit after pregnancy  41 (52.6)  193 (46.7)   
No  35 (44.9)  218 (52.8)   
Smoking      0.344 
Yes  0 (0.0)  0 (0.0)   
Quit after pregnancy  5 (6.33)  15 (3.6)   
No  74 (93.7)  399 (96.4)   
Past medical history      0.192 
Yes  18 (22.8)  67 (16.2)   
No  61 (77.2)  347 (83.8)   
Psychiatric illness      0.071 
Yes  4 (5.1)  5 (1.0)   
No  75 (94.9)  409 (98.8)   
History of abortion      0.066 
Yes  36 (45.6)  137 (33.0)   
No  43 (54.4)  278 (67.0)   
History of preterm delivery      1.000 
Yes  3 (3.8)  20 (4.8)   
No  76 (96.2)  395 (95.2) 
Values are presented as mean ± SD or n (%); BMI, body mass index. 
* obtained by t-test for continuous and chi-square test or Fisher’s exact test for categorical variables. Int. J. Med. Sci. 2012, 9 
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Table 2. Distributions of Edinburgh Postnatal Depression Scale (EPDS) items and differences between “depressed” and 
“not depressed” groups. 
EPDS item  Depressed 
(n = 79) 
Not depressed 
(n = 415) 
P value* 
E1. I have been able to laugh and see the funny side of things  0.46 ± 0.57  0.06 ± 0.24  <0.0001 
E2. I have looked forward with enjoyment to things  1.16 ± 0.79  0.39 ± 0.56  <0.0001 
E3. I have blamed myself unnecessarily when things went wrong  2.32 ± 0.61  1.46 ± 0.79  <0.0001 
E4. I have been anxious or worried for no good reason  2.22 ± 0.57  1.44 ± 0.71  <0.0001 
E5. I have felt scared or panicky for no very good reason  1.85 ± 0.77  0.90 ± 0.74  <0.0001 
E6. Things have been getting on top of me  1.54 ± 0.64  0.71 ± 0.63  <0.0001 
E7. I have been so unhappy that I have had difficulty sleeping  1.53 ± 0.68  0.27 ± 0.54  <0.0001 
E8. I have felt sad or miserable  1.87 ± 0.43  0.47 ± 0.68  <0.0001 
E9. I have been so unhappy that I have been crying  1.33 ± 0.75  0.26 ± 0.53  <0.0001 
E10. The thought of harming myself has occurred to me  0.43 ± 0.65  0.04 ± 0.19  <0.0001 
Total score of EPDS  14.7 ± 12.75  5.98 ± 2.84  <0.0001 
Values are presented as mean ± SD. 
* obtained by t-test. 
 
 
The simplified EPDS 
The  simplified  EPDS  was  designed  with  the 
training set of 250 samples and then cross-validated 
with the validation set of 244 samples.  
The degree of explanation of each EPDS item for 
the EPDS total score is shown in Table 3. Each item 
was highly associated with a positive EPDS screen. 
Item 8 (sadness or misery) scored the highest correla-
tion.  We  defined  the  simplified  instrument  as  the 
simple sum of items of EPDS. Among two-item subset 
models,  we  found  that  the  sum  of  item  5  (scare  or 
panic) and item 8  (sadness or misery) was the best 
two-item subset, explaining 75.5% of the variation of 
EPDS total score and producing an AUC of 95.5%. 
The more items that were added, the better the 
total  score  of  EPDS  was  explained.  For  example, 
among three-item subset models, we found that the 
sum  of  item  5  (scare  or  panic),  item  8  (sadness  or 
misery), and item 4 (anxiety or worry) was the best 
three-item subset, explaining 81.9% of the variation of 
total  EPDS  with  an  AUC  of  94.8%.  However,  these 
results  showed  that  the  three-item  subset  increased 
the power of explanation but decreased the screening 
ability,  as  shown  by  the  AUC,  compared  with  the 
two-item subset. Therefore, we composed the simpli-
fied  questionnaire  based  on  the  sum  of  two  EPDS 
items  that  had  high  R-squares  and  AUCs:  item  5 
(scare or panic) and item 8 (sadness or misery). The 
sum  of  these  two  items  was  reasonably  correlated 
with the total EPDS score, and the approach was also 
the  simplest  in  that  it  used  the  fewest  number  of 
items.  The  performance  of  the  simplified  EPDS 
against total EPDS score is shown in Table 4. Using 
the simplified EPDS, the AUC for antenatal depres-
sive symptoms was 0.955, and a cut-off score of 3 was 
found to be most suitable for screening of depressive 
symptoms. When using a score of 3 as a cut-off value 
of the simplified scale applied to the training set, the 
sensitivity was 0.921 (95% CI, 0.835–1.000), the speci-
ficity  was  0.877  (95%  CI,  0.833–0.922),  the  positive 
predictive value was 0.574 (95% CI, 0.450–0.698), and 
the  negative  predictive  value  was  0.984  (95%  CI, 
0.966–1.000).  
In the validation set, item 8 (sadness or misery) 
scored the highest correlation, and the sum of item 5 
(scare  or  panic)  and  item 8  (sadness  or  misery)  ex-
plained the total score of EPDS most effectively. Ap-
plication  of  the  simplified  scale  produced  the  same 
results  when  applied  to  the  total  study  population 
(Table  3).  The  effectiveness  of  the  simplified  EPDS 
with the validation set and total set are calculated by 
ROC curve analysis. The AUCs were 0.938 and 0.947, 
respectively. As a result, we concluded that the newly 
developed  instrument  performed  well  in  detecting 
pregnant women with depressive symptoms. With a 
cut-off score of 3, the sensitivity was 0.927 (95% CI, 
0.847–1.000),  the  specificity  was  0.847  (95%  CI, 
0.798–0.897), the positive predictive value was 0.551 
(95%  CI,  0.433–0.668),  and  the  negative  predictive 
value was 0.983 (95% CI, 0.964–1.000) in the validation 
set. In the total study population, the sensitivity was 
0.924 (95% CI, 0.866–0.982), the specificity was 0.863 
(95%  CI,  0.830–0.896),  the  positive  predictive  value 
was  0.562  (95%  CI,  0.476–0.647),  and  the  negative 
predictive value was 0.984 (95% CI, 0.970–0.997). 
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Table 3. Degrees of explanation/discrimination of each item for depression. 
Item  Training set 
(n = 250) 
Validation set 
(n = 244) 
Total set 
(n = 494) 
  R2  AUC  R2  AUC  R2  AUC 
E1  0.1174  0.667  0.2159  0.692  0.1660  0.680 
E2  0.3510  0.805  0.2414  0.738  0.2943  0.771 
E3  0.4153  0.791  0.3304  0.763  0.3776  0.778 
E4  0.3934  0.749  0.4304  0.800  0.4084  0.775 
E5  0.4534  0.812  0.4010  0.766  0.4307  0.790 
E6  0.3935  0.762  0.4593  0.834  0.4281  0.798 
E7  0.5251  0.894  0.5284  0.890  0.5279  0.893 
E8  0.5396  0.926  0.5877  0.916  0.5611  0.921 
E9  0.4731  0.858  0.4704  0.843  0.4721  0.852 
E10  0.1878  0.629  0.2634  0.687  0.2273  0.659 
E5 + E8  0.7551  0.955  0.7538  0.938  0.7553  0.947 
E5 + E8 + E4  0.8192  0.948  0.7930  0.950  0.8062  0.950 
R2, coefficient of determination; AUC, area under the receiver-operating characteristic curve 
 
Table 4. Diagnostic abilities of the simplified Edinburgh Postnatal Depression Scale (EPDS) score using cut-off value 3. 
Diagnostic values  Training set 
(n = 250) 
Validation set 
(n = 244) 
Total set 
(n = 494) 
Sensitivity  35/38 (92.1) 
(83.5–100) 
38/41 (92.7) 
(84.7–100) 
73/79 (92.4) 
(86.6–98.2) 
Specificity  186/212 (87.7) 
(83.3–92.2) 
172/203 (84.7) 
(79.8–89.7) 
358/415 (86.3) 
(83.0–89.6) 
PPV  35/61 (57.4) 
(45.0–69.8) 
38/69 (55.1) 
(43.3–66.8) 
73/130 (56.2) 
(47.6–64.7) 
NPV  186/189 (98.4) 
(96.6–100) 
172/175 (98.3) 
(96.4–100) 
358/364 (98.4) 
(97.0–99.7) 
Total accuracy  221/250 (88.4) 
(84.4–92.4) 
210/244 (86.1) 
(81.7–90.4) 
431/494 (87.2) 
(84.3–90.2) 
Values in the second line are 95% confidence intervals. 
PPV, positive predictive value; NPV, negative predict value. 
Values in parentheses are percentages, and 95% confidence intervals are presented in the 
 
 
Discussion 
Routine  antenatal  screening  for  depression  is 
logical because no pregnant women can be considered 
risk  free  (32).  For  this  reason,  identification  of  the 
pregnant  women  who  have  perinatal  depressive 
symptoms is considered a critical goal of the maternal 
care  system  (32-36).  However,  use  of  the  screening 
survey is impractical in busy clinical settings in Korea 
because  the  traditional  screening  questionnaires  re-
quire excessive time for interpretation after the preg-
nant women complete them.  
There have already been attempts to simplify the 
EPDS.  Pallant  et  al.  suggested  a  revised  eight  item 
version  of  EPDS  which  would  show  high  levels  of 
agreement  with  the  original  case  identification  the 
EPDS (37). But, the simplified EPDS consisting of 8 
items  still  needs  a  lot  of  time  to  complete.  In  this 
study, we determined that pre-screening with a sim-
plified EPDS containing two items generally had good 
sensitivity and specificity for identifying women that 
would show positive screening results on the EPDS. 
In accordance with the ROC results, we recommend 
using the simplified EPDS with a cut-off score of 3 to 
detect pregnant women with depressive symptoms. 
This simple screening procedure takes less time and 
may be useful as a tool to rule out women who would 
otherwise require further time-consuming assessment 
for antenatal depressive symptoms. The use of a brief 
and general screening test that is quick and easy to 
administer and score could be utilized for detec-
tion of such depressive symptoms by primary health 
care  providers.  Identifying  perinatal  depressive 
symptoms is important not only for the mother but 
also for the fetus and newborn. The simplified EPDS 
may  have  sufficient  accuracy  to  identify  women  at Int. J. Med. Sci. 2012, 9 
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risk for antenatal depression. A remaining challenge 
is how to link the many women who screen positive 
to professional help. 
Screening  for  depression  is  only  meaningful 
when paired with confirmatory diagnosis and treat-
ment. Goodman et al. reported that detection, treat-
ment, and referral of pregnant women with perinatal 
depression  by  obstetrical  providers  are  seriously 
lacking after analyzing screening results of screening 
for perinatal depression and anxiety in 491 pregnant 
women  (38).  Because  of  the  negative  effects  of  un-
treated perinatal depression and anxiety on mothers 
and infants, it is important that at-risk women are not 
only identified but also treated. Fortunately, effective 
treatments  exist  for  perinatal  depression,  although 
there are some limitations with regard to medications 
during pregnancy and lactation (39-43).  
There are some limitations to our study. First, we 
used the EPDS rather than the clinical diagnosis  of 
depression  as  the  criterion  measure.  However,  the 
goal  of  this  study  was  to  reduce  the  burden  of 
screening  for  antenatal  depression,  not  to  diagnose 
major  depression  disorders  or  to  examine  the  costs 
and benefits of screening, which may produce many 
false positives. Although a variety of measures have 
been used to screen women for depression and anxi-
ety in the antenatal period, including the EPDS, the 
Beck Depression Inventory, the General Health Ques-
tionnaire, the Pregnancy Specific Stress Scale, and the 
Kessler 10 Scale of Psychological Distress, the EPDS is 
a  good  instrument  that  avoids  misinterpreting  bio-
logical symptoms that may be misconstrued as nor-
mal physiological changes associated with pregnancy 
(44). Another limitation of this study is the possibility 
that some participants may have under-reported their 
depressive symptoms on the screening questionnaire. 
  Despite such limitations, our study’s strength is 
that it is the first to attempt simplification of a tradi-
tional screening instrument. In addition, we validated 
the usefulness of the newly developed simplified in-
strument. Based on the results of our study, we can 
propose its use to maternal health care providers who 
want  to  screen  for  antenatal  depression  but  do  not 
have  enough  time  to  use  the  full  screening  instru-
ment.  
Many  women  consider  their  obstetrical  care 
provider  to  be  their  primary  care  provider  during 
their childbearing years (45). Obstetrical care provid-
ers  can  be  the  usual—and  sometimes  only—health 
care providers for women during the perinatal period 
because pregnant women have frequent contact with 
them by way of prenatal visits, hospital delivery, and 
postpartum follow-up. The antenatal visit may pro-
vide the ideal setting in which to screen for depression 
because most pregnant women will get antenatal care 
at  some  point  during  pregnancy  (46-48).  Therefore, 
the importance of the obstetrical health care provid-
er’s role as a primary care provider who can detect 
depressive  symptoms  at  an  early  stage  should  be 
emphasized. A major impediment to depression case 
identification  is  the  difficulty  in  administration  of 
depression  screening  in  busy  clinical  settings.  The 
simplified  EPDS  can  be  an  efficient  instrument  for 
ruling out depression during pregnancy. And women 
who screen positive using the simplified EPDS should 
be followed up with a diagnostic interview. 
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